{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000199","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.549597+00:00","generated_at":"2026-05-24T06:56:30.049838+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MIRA Pharma to acquire SKNY in stock-for-stock deal; adds weight loss drug SKNY-1","bullets":["SKNY contributes $5M in cash/assets at closing, no contingencies.","Exchange ratio determined by independent valuation; subject to SKNY valuation >= MIRA market value.","90-day mutual due diligence period; definitive agreement required within 180 days after.","No SKNY board, executives, or employees will retain roles post-closing.","SKNY stockholders subject to 6-month lock-up on MIRA shares received."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000199","json":"https://secwatch.observer/filing/0001641172-25-000199.json","markdown":"https://secwatch.observer/filing/0001641172-25-000199.md","text":"https://secwatch.observer/filing/0001641172-25-000199.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000164117225000199/0001641172-25-000199-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000164117225000199/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:56:30.049838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}